Steris | Des Atouts



Assets Changement Date
3M USD 37.99B 1.96B 2025-06
Avanos Medical USD 1.04B 68.8M 2025-06
Baxter International USD 21.3B 4.48B 2025-03
Becton, Dickinson and Co. USD 54.47B 198M 2025-03
Boston Scientific USD 40.14B 745M 2025-03
CONMED USD 2.33B 30.78M 2025-06
Cooper Companies USD 12.41B 191.4M 2025-04
Dexcom USD 7.33B 575.3M 2025-06
Ecolab USD 23.74B 1.37B 2025-06
Edwards Lifesciences USD 13.02B 33M 2025-03
Fortive USD 18.24B 1.11B 2025-06
Getinge SEK 63.92B 4.3B 2024-12
Globus Medical USD 4.71B 540.6M 2025-03
Haemonetics USD 2.53B 6.05M 2024-12
Hologic USD 8.81B 261M 2025-06
Idexx Laboratories USD 3.33B 117.1M 2025-06
Insulet USD 3.52B 429.6M 2025-03
Integra LifeSciences USD 3.67B 384.85M 2025-06
Intuitive Surgical USD 20.16B 942.8M 2025-06
J&J USD 193.67B 13.57B 2025-03
Masimo USD 2.29B 332.6M 2025-03
Olympus JPY 1.43T 25.9B 2025-03
Owens Minor USD 4.86B 200.27M 2025-03
ResMed USD 8.17B 607.57M 2025-06
Steris USD 10.15B 138.45M 2025-03
Stryker USD 46.33B 325M 2025-06
Tandem Diabetes Care USD 922.14M 45.52M 2025-03
Teleflex USD 7.38B 211.93M 2025-06
Thermo Fisher Scientific USD 101.23B 2.19B 2025-06
Zimmer Biomet Holdings USD 21.37B 355M 2024-12


Steris Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.